EYES Fail-to-Deliver

Second Sight Medical Products, Inc. (EYES) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $210.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of 2.56 to the broader market. As of August 30, 2022, Second Sight Medical Products, Inc. Led by Matthew Pfeffer, public since 2014-11-19.

Fail-to-deliver (FTD) data from the SEC tracks settlement failures where shares were not delivered within the standard settlement period. Persistent FTDs may indicate naked short selling or settlement issues and are monitored by regulators.

Latest Date

2026-05-14

Latest FTD Quantity

259

Latest Price

$25.05

30-Day Avg FTD

1.2K

30-Day Total FTD

36.8K

Showing 30 days of SEC fail-to-deliver data for Second Sight Medical Products, Inc..

Learn how fails-to-deliver is reported and how to read the data →